MHRA Drug Safety Update: Isotretinoin – changes to prescribing guidance and additional risk minimisation measures
The Commission on Human Medicines (CHM) has endorsed changes to the risk minimisation measures for isotretinoin, following a review of the impact of the measures implemented in 2023. We ask healthcare professionals to review these new measures and supporting materials and integrate them into their clinical practice. Second prescriber no longer required plus updated risk [...]
The post MHRA Drug Safety Update: Isotretinoin – changes to prescribing guidance and additional risk minimisation measures appeared first on Community Pharmacy England.
Recent Comments